Use of the XRCC2 promoter for in vivo cancer diagnosis and therapy.
Chen Y, Li Z, Xu Z, Tang H, Guo W, Sun X, Zhang W, Zhang J, Wan X, Jiang Y, Mao Z.
Chen Y, et al. Among authors: guo w.
Cell Death Dis. 2018 Apr 1;9(4):420. doi: 10.1038/s41419-018-0453-9.
Cell Death Dis. 2018.
PMID: 29549248
Free PMC article.